Efficacy of comfrey in foot ulcerations related to diabetes
a randomized controlled and double-blind clinical trial
DOI:
https://doi.org/10.23925/1984-1840.2024v26a34Keywords:
Comfrey, Ulcer, Diabetes Mellitus, Wound HealingAbstract
Objective: To evaluate the effects of external use of comfrey on diabetes-related foot ulceration in the outpatient stomatherapy nursing clinic of a quaternary public teaching hospital. Methods: This is a randomized-controlled, parallel, double-blind, two-arm, quantitative clinical trial conducted with 19 participants. The control group used hydrogel, while the intervention group used a 5% ointment made from the aqueous extract of comfrey leaves. The groups used the formula for 60 days, applying it every 24 hours, and were reassessed every 15 days. To collect data, an instrument was used consisting of a section with clinical information related to the injury and another dedicated to the measurements and dimensions of the injury. Results: There was an increase in the percentage of lesion contraction in the group using 5% comfrey on the 15th (p < 0.05), 30th (p < 0.01), 45th (p < 0.05) and 60th (p < 0.05) days of treatment, rapid improvement in the Texas classification and in the predominance of granulation tissue after the 15th day, in relation to the control group. Conclusion: The analysis of this study's results, it was possible to observe that comfrey promoted faster healing, decreased exudate and pain levels, improved Texas classification, tissue repair in a shorter time, increased percentage of lesion contraction, and improved tissue perfusion.
Downloads
Metrics
References
American Diabetes Association. American Diabetes Association Releases 2023 Standards of Care in Diabetes to Guide Prevention, Diagnosis, and Treatment for People Living with Diabetes [Internet]. 2023 [acesso em 11 mar. 2024]. Disponível em: https://diabetes.org/newsroom/american-diabetes-association-2023-standards-care-diabetes-guide-for-prevention-diagnosis-treatment-people-living-with-diabetes.
PAHO/WHO. Number of people with diabetes in the Americas more than tripled in three decades. Pan American Health Organization [Internet]. 2022 Nov 11 [acesso em 11 mar. 2024]. Disponível em: https://www.paho.org/en/news/11-11-2022-number-people-diabetes-americas-has-more-tripled-three-decades-paho-report-says.
Muzy J, Campos MR, Emmerick I, Silva RS, Schramm JMA. Prevalência de diabetes mellitus e suas complicações e caracterização das lacunas na atenção à saúde a partir da triangulação de pesquisas. Cad Saúde Pública. 2021;37(5):e00076120. doi: 10.1590/0102-311X00076120.
Goyal R, Singhal M, Jialal I. Type 2 Diabetes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan [acesso em 11 mar. 2024]. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK513253/.
Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Fitridge R, Game F, et al; IWGDF Editorial Board. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3657. doi: 10.1002/dmrr.3657.
Chang M, Nguyen TT. Strategy for treatment of infected diabetic foot ulcers. Acc Chem Res. 2021;54(5):1080-1093. doi: 10.1021/acs.accounts.0c00864.
Gonçalves ACO, Cazarim MS, Sanches C, Pereira LRL, Camargos AMT, Aquino JA, et al. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2019;7(1):e000647. doi: 10.1136/bmjdrc-2018-000647.
Pinto JM, Pizani NS, Kang HC, Silva LA. Application of platelet-rich plasma in the treatment of chronic skin ulcer - case report. An Bras Dermatol. 2014;89(4):638-40. doi: 10.1590/abd1806-4841.20143004.
Chen CY, Zhang JQ, Li L, Guo MM, He YF, Dong YM, et al. Advanced glycation end products in the skin: molecular mechanisms, methods of measurement, and inhibitory pathways. Front Med (Lausanne). 2022;9:837222. doi: 10.3389/fmed.2022.837222.
Ferrari R, Barbosa AM, Lano MED, Ornelas SS, Barbosa ACP. Confrei (symphitum officinaly) aspectos botânicos, fitoquímicos e terapêuticos. Ensaios e ciências: ciências biológicas, agrária e da saúde. Ensaios Ciênc: Ciênc Biol Agr Saúde. 2012;16(6):227-37. doi: 10.17921/1415-6938.2012v16n6p%25p.
Neagu E, Paun G, Albu C, Eremia SAV, Radu GL. Artemisia abrotanum and symphytum officinale polyphenolic compounds-rich extracts with potential application in diabetes management. Metabolites. 2023;13(3):354. doi: 10.3390/metabo13030354.
Mahmoudzadeh E, Nazemiyeh H, Hamedeyazdan S. Anti-inflammatory properties of the genus symphytum l.: a review. Iran J Pharm Res. 2022;21(1):e123949. doi: 10.5812/ijpr.123949.
Escosteguy CC. Tópicos metodológicos e estatísticos em ensaios clínicos controlados randomizados. Arq Bras Cardiol. 1999;72(2):139-43.
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução da Diretoria Colegiada – RDC nº 17, de 16 de abril de 2010. Dispõe sobre Boas Práticas de fabricação de Medicamentos. Diário Oficial da União, Poder Executivo, Brasília, DF. 2010.
Ferreira RC. Pé diabético. Parte 1: Úlceras e infecções. Rev Bras Ortop. 2020;55(4):389–96. doi: 10.1055/s-0039-3402462.
Ruzicka J, Berger-Büter K, Esslinger N, Novak J. Assessment of the diversity of comfrey (Symphytum officinale L. and S. × uplandicum Nyman). Genet Resour Crop Evol. 2021;68:2813-25. doi: 10.1007/s10722-021-01156-x.
Trifan A, Opitz SEW, Josuran R, Grubelnik A, Esslinger N, Peter S, et al. Is comfrey root more than toxic pyrrolizidine alkaloids? Salvianolic acids among antioxidant polyphenols in comfrey (Symphytum officinale L.) roots. Food Chem Toxicol. 2018;112:178-87. doi: 10.1016/j.fct.2017.12.051.
Crocker RM, Palmer KNB, Marrero DG, Tan TW. Patient perspectives on the physical, psycho-social, and financial impacts of diabetic foot ulceration and amputation. J Diabetes Compl. 2021;35(8):107960. doi: 10.1016/j.jdiacomp.2021.107960.
Kurniawati A, Ismiarto YD, Hsu IL. Prognostic factors for lower extremity amputation in diabetic foot ulcer patients. J Acute Med. 2019;9(2):59–63. doi: 10.6705/j.jacme.201906_9(2).0003
Syarifah AN, Suryadi H, Hayun H, Simamora A, Mun'im A. Detoxification of comfrey (Symphytum officinale L.) extract using natural deep eutectic solvent (NADES) and evaluation of its anti-inflammatory, antioxidant, and hepatoprotective properties. Frontiers Pharmacol. 2023;14:1012716. doi: 10.3389/fphar.2023.1012716.
Salehi B, Sharopov F, Boyunegmez Tumer T, Ozleyen A, Rodríguez-Pérez C, Ezzat SM, et al. Symphytum species: a comprehensive review on chemical composition, food applications and phytopharmacology. Molecules (Basel, Switzerland). 2019;24(12):2272. doi: 10.3390/molecules24122272.
Sowa I, Paduch R, Strzemski M, Zielińska S, Rydzik-Strzemska E, Sawicki J, et al. Proliferative and antioxidant activity of Symphytum officinale root extract. Nat Product Res. 2018;32(5):605–9. doi: 10.1080/14786419.2017.1326492.
Nastić N, Borrás-Linares I, Lozano-Sánchez J, Švarc-Gajić J, Segura-Carretero A. comparative assessment of phytochemical profiles of comfrey (symphytum officinale l.) root extracts obtained by different extraction techniques. Molecules (Basel, Switzerland). 2020;25(4):837. doi: 10.3390/molecules25040837.
Moraes GV, Jorge GM, Gonzaga RV, Santos DA. Antioxidant potential of flavonoids and therapeutic applications. Res Soc Dev. 2022;11(14):e238111436225. doi: 10.33448/rsd-v11i14.36225.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista da Faculdade de Ciências Médicas de Sorocaba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Os autores no momento da submissão transferem os direitos autorais, assim, os manuscritos publicados passam a ser propriedade da revista.
O conteúdo do periódico está licenciado sob uma Licença Creative Commons 4.0, esta licença permite o livre acesso imediato ao trabalho e que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreando-os para indexação, passá-los como dados para o software, ou usá-los para qualquer outra finalidade legal.